October 6, 2021

VACCINE ALTERNATIVES: AstraZeneca seeks FDA emergency approval for antibody COVID-19 drug. “When it announced the results of its late-stage trial on Aug. 20, AstraZeneca explained the drug, which is delivered by intramuscular injection, could provided up to 12 months’ protection from the virus.”

InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.